SCHEMBL10517463

SCHEMBL10517463

CN(C)S(=O)(=O)c1cnc(N)c(N)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 1/20 0.44
▸ ALDH1A1 P00352 7/20 0.43
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ POLB P06746 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.38
▸ MAP4K1 Q92918 2/20 0.38
▸ HTT P42858 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ NPSR1 Q6W5P4 3/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ PIK3C3 Q8NEB9 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ RXFP1 Q9HBX9 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ TNF P01375 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ NOD1 Q9Y239 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18293426 0.84 ALDH1A1 (0.42) KCNH2ALDH1A1MEN1KMT2APOLB
SCHEMBL26804195 0.84 NOS3 (0.47) KCNH2ALDH1A1MEN1KMT2APOLB
SCHEMBL26647445 0.80 MAPT (0.50) KCNH2ALDH1A1KMT2APOLBPKM
SCHEMBL913896 0.79 MAP4K4 (0.43) KCNH2KDM4E
SCHEMBL18293428 0.78 PIK3C3 (0.40) KCNH2ALDH1A1MEN1KMT2APOLB
SCHEMBL11642192 0.77 ALDH1A1 (0.61) KCNH2ALDH1A1MEN1KMT2APOLB
SCHEMBL2252618 0.72 KDM4E (0.58) KCNH2ALDH1A1MEN1KMT2APOLB
SCHEMBL3064504 0.72 PIK3C3 (0.42) KCNH2ALDH1A1MEN1KMT2APOLB
SCHEMBL914479 0.71 ALDH1A1 (0.64) ALDH1A1MEN1KMT2APOLBPKM
SCHEMBL3709323 0.70 ALDH1A1 (0.68) ALDH1A1POLBPKMLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0308917-A2 Imidazopyridine compound, a process for preparation thereof and pharmaceutical compositions comprising them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-03-29 — — EP disclosed
Send feedback